» Articles » PMID: 1703360

Histopathology of Human Renal Allograft Rejection Under FK 506: a Comparison with Cyclosporine

Overview
Journal Transplant Proc
Specialty General Surgery
Date 1991 Feb 1
PMID 1703360
Citations 12
Authors
Affiliations
Soon will be listed here.
Citing Articles

Pediatric renal transplantation under tacrolimus-based immunosuppression.

Shapiro R, Scantlebury V, Jordan M, Vivas C, Ellis D, Gilboa N Transplantation. 1999; 67(2):299-303.

PMID: 10075598 PMC: 2975962. DOI: 10.1097/00007890-199901270-00020.


Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.

Demetris A, Murase N, Lee R, Randhawa P, Zeevi A, Pham S Ann Transplant. 1997; 2(2):27-44.

PMID: 9869851 PMC: 3235804.


Tacrolimus in pediatric renal transplantation.

Shapiro R, Scantlebury V, Jordan M, Vivas C, Gritsch H, Ellis D Transplantation. 1996; 62(12):1752-8.

PMID: 8990356 PMC: 2987655. DOI: 10.1097/00007890-199612270-00010.


The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience.

Shapiro R, Jordan M, Scantlebury V, Vivas C, Gritsch H, Corry R Clin Transpl. 1995; :199-205.

PMID: 8794266 PMC: 2991087.


Immunosuppressant FK506 induces interleukin-6 production through the activation of transcription factor nuclear factor (NF)-kappa(B). Implications for FK506 nephropathy.

Muraoka K, Fujimoto K, Sun X, Yoshioka K, Shimizu K, Yagi M J Clin Invest. 1996; 97(11):2433-9.

PMID: 8647935 PMC: 507328. DOI: 10.1172/JCI118690.


References
1.
Todo S, Fung J, Demetris A, Jain A, Venkataramanan R, Starzl T . Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc. 1990; 22(1):13-6. PMC: 2903882. View

2.
Fung J, Todo S, Jain A, McCauley J, Alessiani M, Scotti C . Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc. 1990; 22(1):6-12. PMC: 2903869. View

3.
Demetris A, Fung J, Todo S, Banner B, Zerbe T, Sysyn G . Pathologic observations in human allograft recipients treated with FK 506. Transplant Proc. 1990; 22(1):25-34. PMC: 2903856. View